Ann: Dr Ron Weinberger appointed Executive Chairman - Updated, page-3

First 3 Last

Share
Profile

Follow
dunnomuch

2,243 Posts.

916

03/07/23

12:40

Post #: 68587857
Share

Originally posted by thecableguy: ↑

Shuffling chairs here or getting serious??

"Ron has been Non-Executive Chairman of HeraMED since August 2018 during which time he has assisted management in progressing the business from its developmental phase to the current phase that sees HeraMED on the cusp of broader commercialisation, particularly in the key target markets of USA and Australia."

Are we going to get extra special Ron now? Has he been holding things back since 2018 and now we get full access to his black book??

Not sure on how these games play out, but the only paragraph that I was keen on was:

"As HeraMED Executive Chairman, Ron will bring his significant experience to all aspects of the commercialisation process including manufacturing, sales and marketing, a focus on non-dilutive funding as well as revenue growth all with a view to the creation of shareholder value. "

Non dilutive funding, bring it on ASAP please Dr. Ron.

Shareholder value, yes well there would be less than 1% of holders that is above there average buy in price, this bit wont be too hard to achieve.

Hope he can deliver on both of those "views".

Regards to all, and stay in your crease...

Just another opinion.

TCG

Expand

you're getting a Johnny Bairstow t-shirt for the Bruns mate...

by the time the cricket is on in Brisbane we are either going to be saying cheers to a company on the move at the mighty Brunswick Heads pub or nursing an almighty tax loss... I'm betting on the former so you better get your leave pass sorted.

HMD Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

HAR

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.2¢		Change 0.000(0.00%)		Mkt cap ! $10.50M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.2¢	$1.59K	132.5K

Buyers (Bids)

No.	Vol.	Price($)
1	563500	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	500000	1

View Market Depth

No.	Vol.	Price($)
1	563500	0.012
2	542283	0.011
2	2300098	0.010
1	1000000	0.009
2	425120	0.008

Price($)	Vol.	No.
0.013	500000	1
0.015	1144298	2
0.016	2197553	2
0.019	200000	1
0.025	46598	1

Last trade - 14.32pm 30/07/2025 (20 minute delay)

HMD (ASX) Chart

Ann: Dr Ron Weinberger appointed Executive Chairman - Updated, page-3

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Neurizon inks $1.5M loan against R&D Tax Rebate

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Dr Ron Weinberger appointed Executive Chairman - Updated, page-3

Top Stories

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Neurizon inks $1.5M loan against R&D Tax Rebate

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News